company-logo

Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment of amyotrophic lateral sclerosis. It is also developing AMX0035 for other neurodegenerative diseases. The company was founded in 2013 and is headquartered in Cambridge, Massachusetts.

Amylyx Pharmaceuticals Dividend Announcement

Amylyx Pharmaceuticals announced a annually dividend of $0.42 per ordinary share which will be made payable on 2018-04-02. Ex dividend date: 2018-03-28
Amylyx Pharmaceuticals's trailing twelve-month (TTM) dividend yield is -%

Amylyx Pharmaceuticals Dividend History

Ex-Div dateDividend amountDividend typePay date
2018-03-28$0.42annually2018-04-02
2017-12-28$0.36annually2018-01-02
2017-09-28$0.24annually2017-10-02

Amylyx Pharmaceuticals Dividend per year

Amylyx Pharmaceuticals Dividend Yield

Amylyx Pharmaceuticals current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Amylyx Pharmaceuticals stock? Use our calculator to estimate your expected dividend yield:

Amylyx Pharmaceuticals Financial Ratios

P/E ratio-1.49
PEG ratio0.07
P/B ratio1.96
ROE-85.39%
Payout ratio0.00%
Current ratio4.55
Quick ratio4.55
Cash Ratio1.33

Amylyx Pharmaceuticals Dividend FAQ

Does Amylyx Pharmaceuticals stock pay dividends?
Amylyx Pharmaceuticals does not currently pay dividends to its shareholders.
Has Amylyx Pharmaceuticals ever paid a dividend?
No, Amylyx Pharmaceuticals has no a history of paying dividends to its shareholders. Amylyx Pharmaceuticals is not known for its dividend payments.
Why doesn't Amylyx Pharmaceuticals pay dividends?
There are several potential reasons why Amylyx Pharmaceuticals would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Amylyx Pharmaceuticals ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Amylyx Pharmaceuticals has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Amylyx Pharmaceuticals a dividend aristocrat?
Amylyx Pharmaceuticals is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Amylyx Pharmaceuticals a dividend king?
Amylyx Pharmaceuticals is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Amylyx Pharmaceuticals a dividend stock?
No, Amylyx Pharmaceuticals is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Amylyx Pharmaceuticals stocks?
To buy Amylyx Pharmaceuticals you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Amylyx Pharmaceuticals stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.